In one of the largest biotechnology deals of 2026, the UK’s GSK announced it will acquire Nuvalent, a US-based clinical-stage biotechnology company, …
Incyte Corporation is set to purchase Vega Therapeutics, a wholly owned subsidiary of Star Therapeutics, strengthening its position in hematology. The Incyte …
The recent findings from the Survodutide weight-loss drug trial by Boehringer Ingelheim were released recently. Licensed from Denmark’s Zealand Pharma, the experimental …
A major breakthrough in women’s cancer care has arrived in England after the approval of the new ovarian cancer drug Elahere (mirvetuximab …
In a scientific breakthrough, an AI-designed vaccine for viruses has successfully completed its first human clinical trial, marking a significant step toward …
One of the world’s largest nutrition companies, Nestlé, is collaborating with Helaina Inc., an emerging biotechnology innovator from the USA, to study …
The Abivax bowel disease drug trial has produced encouraging late-stage results, bringing the French biotechnology company one step closer to introducing a …
The global effort toward Bundibugyo Ebola vaccine development has entered a critical phase as international health organizations, governments, and vaccine developers mobilize …
The new pancreatic cancer pill Daraxonrasib by Revolution Medicines has delivered one of the most significant advances in pancreatic cancer treatment in …
New findings from the J&J prostate cancer drug study presented at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting suggest …
In the Pfizer and Innovent Biologics deal, the two pharmaceutical companies announced a strategic oncology partnership worth up to $10.5 billion. Pfizer’s …
World Health Organization Director-General Tedros Adhanom Ghebreyesus arrived in the country this week as the Democratic Republic of the Congo (DRC) battles …
In one of the largest biotechnology deals of 2026, the UK’s GSK announced it will acquire Nuvalent, a US-based clinical-stage
Incyte Corporation is set to purchase Vega Therapeutics, a wholly owned subsidiary of Star Therapeutics, strengthening its position in hematology.
The recent findings from the Survodutide weight-loss drug trial by Boehringer Ingelheim were released recently. Licensed from Denmark’s Zealand Pharma,
A major breakthrough in women’s cancer care has arrived in England after the approval of the new ovarian cancer drug
In a scientific breakthrough, an AI-designed vaccine for viruses has successfully completed its first human clinical trial, marking a significant
One of the world’s largest nutrition companies, Nestlé, is collaborating with Helaina Inc., an emerging biotechnology innovator from the USA,
The Abivax bowel disease drug trial has produced encouraging late-stage results, bringing the French biotechnology company one step closer to
The global effort toward Bundibugyo Ebola vaccine development has entered a critical phase as international health organizations, governments, and vaccine
The new pancreatic cancer pill Daraxonrasib by Revolution Medicines has delivered one of the most significant advances in pancreatic cancer
New findings from the J&J prostate cancer drug study presented at the American Society of Clinical Oncology (ASCO) 2026 Annual
In the Pfizer and Innovent Biologics deal, the two pharmaceutical companies announced a strategic oncology partnership worth up to $10.5
World Health Organization Director-General Tedros Adhanom Ghebreyesus arrived in the country this week as the Democratic Republic of the Congo
